Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Arovella Therapeutics Limited ( (AU:ALA) ) has issued an announcement.
Arovella Therapeutics Limited has released a report detailing the top 20 holders of its listed options, which are set to expire on May 24, 2027, with an exercise price of $0.15. The report highlights that BNP Paribas Noms Pty Ltd holds the largest share at 9.35%, followed by Netwealth Investments Limited at 4.71%. The total issued capital stands at 39,905,625, with the top 20 holders accounting for 63.06% of this total. This report provides insights into the company’s shareholder structure, which could influence investor perceptions and market dynamics.
More about Arovella Therapeutics Limited
YTD Price Performance: -35.29%
Average Trading Volume: 1,534,508
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$117.1M
See more insights into ALA stock on TipRanks’ Stock Analysis page.